Why do Regenyal injectables
stand out from the others?
Because they are obtained through a long-lasting cross-linking process at low temperatures (gentle cross-linking).
Slow mixing allows the cross-linking agent BDDE to spread better and more uniformly.
It is worth to point out that the amount of BDDE used in these products is 30 per cent lower than in the ones manufactured by competitors.
In addition, different molecular weights of Hyaluronic Acid implemented make it possible to calibrate better the viscosity properties of the material, according to foreseen mode and area of use.
Therefore the Regenyal products are extremely homogeneous and thixotropic. We are speaking about mono-phase gels that, while being free of particles and composed of one fluid jelly-like phase, penetrate into the tissues and spread excellently, and – last but not least – are more persistent. The innovative manufacturing method is covered by an International Patent.
